Rebiotix to Present Data From First-In-Class Microbiota Restoration Therapy at IDWeek 2018

Rebiotix Inc., part of the Ferring Pharmaceuticals Group, announced on 10/1/18 that data new from their Microbiota Restoration Therapy™ (MRT) drug development platform will be presented at the annual Infectious Disease conference, which will be held October 3-7 in San Francisco.